| Date | Meeting | Main Agenda | Resolution |
| 2014.03.24 | 1st Board Meeting | Agenda 1: The Company’s 2013 (Year 102) financial statements submitted for review. Agenda 2: The Company’s 2013 Business Report and Deficit Compensation Statement submitted for discussion. Agenda 3: Completion of the 2013 internal control self-assessment and proposed issuance of the Internal Control System Statement submitted for discussion. Agenda 4: Amendments to the “Procedures for Acquisition or Disposal of Assets” submitted for discussion. Agenda 5: Proposal to appoint a designated custodian of registered company seals submitted for discussion. Agenda 6: Arrangements for convening the 2014 (Year 103) Annual Shareholders’ Meeting submitted for discussion. |
1. Approved as proposed; after CPA audit and certification, to be submitted to the shareholders’ meeting for acknowledgment. 2. Approved as proposed; to be submitted to the Audit Committee for review and then to the shareholders’ meeting for acknowledgment. 3. Approved as proposed. 4. Approved as proposed and submitted to the shareholders’ meeting for discussion. 5. Approved as proposed; authorization for seal custody to be adjusted in accordance with internal control procedures. 6. Approved as proposed. |
| 2014.05.09 | 2nd Board Meeting | Agenda 1: The Company’s 2014 Q1 financial report submitted for review. Agenda 2: Civil construction contract for the GMP API plant, PIC/S pharmaceutical plant and administration building submitted for discussion. Agenda 3: Establishment of the “Regulations for Selection and Assessment of Certifying CPAs” submitted for discussion. Agenda 4: Assessment of the independence of the CPAs engaged for 2014 (Year 103) submitted for review. |
1. Approved as proposed. 2. Approved as proposed. 3. Approved as proposed. 4. Approved as proposed. |
| 2014.08.01 | 3rd Board Meeting | Agenda 1: The Company’s 2014 Q2 financial report submitted for review. Agenda 2: Letter of guarantee matters for the “SR-T100 gel in Phase II clinical trial for treatment of external genital warts” submitted for discussion. Agenda 3: Commissioning of the “electrical, fire protection and low-voltage systems” and “HVAC and process systems” works for construction of the GMP API plant, PIC/S pharmaceutical plant and administration building submitted for discussion. |
1. Approved as proposed. 2. Approved as proposed. 3. Approved as proposed. |
| 2014.11.07 | 4th Board Meeting | Agenda 1: Amendments to the Company’s Internal Control System submitted for discussion. Agenda 2: Commissioning of the “electrical, fire protection and low-voltage systems” and “HVAC and process systems” works for construction of the GMP API plant, PIC/S pharmaceutical plant and administration building submitted for discussion. |
1. Approved as proposed. 2. Approved as proposed. |
| 2014.12.19 | 5th Board Meeting | Agenda 1: The 2015 (Year 104) Budget Proposal submitted for discussion. Agenda 2: Amendments to the Company’s Internal Control System submitted for discussion. Agenda 3: The 2015 Audit Plan submitted for discussion. Agenda 4: Amendments to the “Ethical Corporate Management Guidelines” submitted for discussion. |
1. The 2015 Budget Proposal was approved as proposed. 2. The amendments to the Internal Control System were approved as proposed. 3. The 2015 Audit Plan was approved as proposed. 4. Approved as proposed. |
